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Abstract
The skin and especially the stratum corneum (SC) act as a barrier and pro-
tect epidermal cells and thus the whole body against xenobiotica of the exter-
nal environment. Topical skin treatment requires an efficient drug delivery
system (DDS). Polymer-based nanocarriers represent novel transport vehicles
for dermal application of drugs. In this study dendritic core-multishell (CMS)
nanoparticles were investigated as promising candidates. CMS were loaded
with a drug (analogue) and were applied to penetration studies of skin. We
determined by dual-frequency electron paramagnetic resonance (EPR) how
Dexamethasone (Dx) labelled with 3-carboxy-2,2,5,5-tetramethyl-1-pyrroli-
dinyloxy (PCA) is associated with the CMS. The micro-environment of the
drug loaded to CMS nanoparticles was investigated by pulsed high-field EPR
at cryogenic temperature, making use of the fact that magnetic parameters
(g-, A-matrices, and spin-lattice relaxation time) represent specific probes for
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the micro-environment. Additionally, the rotational correlation time of spin-
labelled Dx was probed by continuous wave EPR at ambient temperature,
which provides independent information on the drug environment. Further-
more, the penetration depth of Dx into the stratum corneum of porcine skin
after different topical applications was investigated. The location of Dx in
the CMS nanoparticles is revealed and the function of CMS as penetration
enhancers for topical application is shown.
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1. Introduction1
Today delivery and controlled release of drugs to specific targets are im-2
portant fields in medical, pharmaceutical, and multi-disciplinary research.3
Different carrier systems have been developed in the last decades, ranging4
from macromolecules to nanoparticles. These vehicles can improve the up-5
take and penetration of drugs into the skin and reduce side effects [1–3]6
Especially for the hair follicles, an improved penetration could be demon-7
strated [4–7] Pharmaceutically used drugs show various physical and chemi-8
cal properties, thus the use of carrier systems is depending on the respective9
drug and its application [8]. Polymer-based nanocarriers are candidates for10
drug delivery systems (DDS) [9–11] and have various advantages: drug car-11
rier development is less time and cost demanding compared to new and more12
2
efficient drugs; nanocarriers can reduce drug side effects and can enhance13
treatment efficiency of diseases due to lower dose requirements. Another14
nanocarrier advantage is the protection of drugs against degradation before15
release at the target [12]. Furthermore, they enable the transport of a mul-16
titude of different drugs with different chemical properties [13].17
Dendritic core-multishell (CMS) nanoparticles represent a class of new nanop-18
articles applicable as DDS [9, 14]. These particles consist of a dendritic poly-19
glycerol core with polar properties, which is surrounded by two layers of dif-20
ferent chemical composition, allowing the transport and storage of molecules21
with lipophilic (inner shell) or hydrophilic (outer shell) character [15–17].22
Recently, these CMS nanoparticles have successfully been used for dermal23
application. Küchler et al. could show an increased penetration for the24
lipophilic fluorescence dye nile red loaded to CMS particles into porcine skin25
compared to a base cream or solid lipid nanoparticles (SLN) [18]. Addition-26
ally, an increased penetration for 3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidi-27
nyloxy (PCA) loaded to CMS nanoparticles was shown in comparison to ultra28
flexible vesicles and aqueous solution by EPR [14].29
Two major questions have to be addressed for future applications of CMS as30
DDS in topical treatments: 1. How can a pharmaceutical be efficiently loaded31
to the DDS, and 2. how is it released upon application onto the target? A32
prerequisite for answering both questions is knowledge about the location of33
the drug within the DDS and its mobility before and after topical applica-34
tion.35
Electron paramagnetic resonance (EPR) spectroscopy is a well-developed36
spectroscopic method for the determination of the micro-environment of a37
3
paramagnetic molecule [19, 20].38
The applicability of spin labels as probes within a carrier system and the39
analysis of their penetration profile into excised porcine ear skin was previ-40
ously shown [14, 17, 21]. In the present study the location of pharmaceuticals41
in CMS nanoparticles, the drug penetration into the porcine ear skin, and42
the possible release of the drug to the strateum corneum (SC) were investi-43
gated by dual-frequency EPR spectroscopy. As a model drug we used the44
lipophilic (logP= 1.83) [22] antiinflammatory glucocorticoid Dexamethasone45
(Dx). Since Dx is diamagnetic and thus not EPR active it was labelled46
by the spin marker PCA, which increases the molecular weight form 392.4747
g/mol for Dx to 560.68 g/mol for DxPCA. Even tough PCA is a hydrophilic48
compound (logP= −1.7 [14, 23]), its attachment to Dx by esterification [24]49
leaves the partitioning coefficient almost unaltered (logP= 1.89 ± 0.02 for50
DxPCA [25]). The Zeeman interaction and the prominent nitrogen hyper-51
fine coupling (g- and A-matrix) as well as the spin-lattice relaxation time52
of the unpaired electron on a nitroxide are highly sensitive probes for the53
surrounding micro-environment properties. [26, 27]. We investigated these54
magnetic parameters for DxPCA by pulsed W-band (94 GHz) EPR spec-55
troscopy at cryogenic temperature (80K). Room temperature EPR spectra56
at X-band [28, 29] were used to investigate the drug mobility within the car-57
rier and its penetration into the porcine ear skin. The latter is possible since58
the rate of PCA reaction with the skin antioxidant system is slow enough to59
allow investigations on porcine ear skin [30, 31].60
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2. Materials and Methods61
2.1. Sample preparation62
The synthesis of DxPCA will be described elsewhere [24]. DxPCA was63
loaded to CMS nanoparticles by an entrapment film method: First, DxPCA64
was dissolved in ethanol, afterwards the solvent was evaporated and dried65
under vacuum condition yielding a thin DxPCA film on the surface of the66
glass container. Second, the CMS nanoparticles in aqueous solution (5 g/L)67
were added to the DxPCA thin film. The solution was stirred for 22 hours68
at 1200 rpm. At the end, the solution was filtered through a 0.45 µm regen-69
erated cellulose (RC) filter.70
The concentration of DxPCA in different solvents used as reference samples71
was 50 µM, except for the solvent toluene where it was 25 µM. DxPCA dis-72
solves only poorly in water (already Dx has a poor solubility of 89 mg/L at73
room temperature [32]). Thus, for achieving the desired DxPCA concentra-74
tion in water, the solution was sonicated and heated up to 70 ◦C for thirty75
minutes and afterwards diluted. Finally, this solution was centrifuged and76
aggregated parts were removed by taking the supernatant.77
The samples used for the measurements at W-band frequencies were frozen78
immediately before the experiments in liquid nitrogen. For improving the79
sample homogeneity upon freezing, glycerol was added in a 1:1 ratio to the80




For the skin penetration studies porcine ear skin was utilised, which was84
shown to be a suitable model for human skin [33, 34]. The porcine ears85
were delivered by a local butcher with approval by the Veterinäramt Berlin86
(Treptow-Köpenick) on the day of slaughter and were cleaned as previously87
described [17]. For the EPR measurements only the backside of the ears88
was used. The uppermost skin layer of the porcine ears was cut-off by a89
dermatome (Dermatom Typ GA 140, Aesculap-Werke AG, Tuttlingen, Ger-90
many) in a thickness of around 400 µm. For the penetration studies, 90 µM91
DxPCA dissolved in an aqueous solution (water/5% EtOH) and loaded into92
CMS particles (dissolved in water/5% EtOH) were applied (20 µL/cm2) even93
on porcine ear skin, followed by a storage in a skin chamber at 32 ◦C [35]. For94
investigations into deeper porcine ear skin layers, the tape stripping method95
was performed as previously described [36]. For these measurements, skin96
slices with a diameter of 4.5 mm were punched-out by using a punch pliers97
Typ3519 (R. Lühdorff GmbH Famex-Werkzeuge, Remscheid, Germany).98
2.3. EPR spectroscopy and analysis99
Cryogenic temperature (80 K) measurements at W-band (94 GHz) were100
performed on a Elexsys E680 EPR spectrometer equipped with a Teraflex101
EN600-1021H probe head (both Bruker Biospin, Karlsruhe, Germany). The102
temperature was controlled by an ITC503 (Oxford Instruments, Oxfordshire,103
United Kingdom). The magnetic field was calibrated by using N@C60 before104
each measurement [37]. Quartz capillaries with 0.87 mm/0.7 mm outer/inner105
diameters (OD/ID) (VitroCom Inc. Mountain Lakes, NJ, USA) were used106
for the W-band measurements. All spectra at W-band were recorded in the107
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field sweep echo (FSE) mode [38]. A 0.5 mT pseudo modulation amplitude108
was used to numerically calculate first derivative spectra [39]. The character-109
istic longitudinal relaxation time T1 was measured by an inversion recovery110
experiment [40], i.e. a inversion pi-pulse followed by a Hahn echo detection111
sequence with incrementing time between inversion and detection.112
Room temperature measurements were performed on two different X-band113
(9 GHz) spectrometers. For spin label mobility measurements we used a114
lab built spectrometer consisting of a Bruker (Rheinstetten, Germany) ER115
041 MR microwave bridge controlled by a Bruker ER 048 R microwave116
bridge controller, a Bruker E088 100-controlled AEG electromagnet, and117
a Bruker 4122 SHQE-W1 microwave resonator(Bruker Biospin, Karlsruhe,118
Germany). Lock-in amplification was done by a Stanford Research Systems119
SR810 DSP Lock-In Amplifier and the microwave frequency measured by an120
Agilent 53181A Frequency Counter. Here samples were placed in 2 mm/1121
mm (OD/ID) quartz capillaries (QSIL GmbH, Langewiesen, Germany). The122
porcine ear skin measurements were performed after 4 and 24 hours incu-123
bation time at ambient temperature (21 ◦C) by using a Elexsys E500 spec-124
trometer including a TMHS resonator, a tissue cell (ER 162TC-Q) and a125
rapid scan unit (all Bruker BioSpin, Karlsruhe, Germany). These measure-126
ments were performed in triplicate on different porcine ear skin samples. All127
EPR spectra were analysed with the Easyspin [41], Matlab (The MathWorks128
GmbH, Ismaning, Germany) toolbox.129
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3. Results and discussion130
3.1. Micro-environment of DxPCA loaded to CMS nano-particles131
The loading into and location of DxPCA in the CMS nanoparticles were132
investigated by probing the DxPCA micro-environment polarity. The sensi-133
tivity of W-band EPR spectra of DxPCA on different environments is shown134
in Fig. 1 for the extreme cases of the highly polar solvent water and the135
highly apolar solvent toluene together with the spectrum of DxPCA loaded136
to CMS. Besides water and toluene, we have examined six additional solvents137
and solvent mixtures as polarity/proticity references. The g- and A-matrices138
for DxPCA in the different environments are listed in table 1. We have chosen139
to use Reichardt’s ENT value [42] as parameter for correlating the measured140
magnetic parameters with the solvent polarity/proticity properites. The de-141
pendence of the gxx and Azz components on ENT is plotted in Fig. 2. Figure 2142
shows the well known trend of the g-matrix principal value gxx shifting to-143
wards lower values from apolar/aprotic to polar/protic solvents, and on other144
hand the nitrogen hyperfine coupling A-matrix principal value Azz shifting145
towards higher values [43]. The changes in gxx and Azz are governed by the146
proticity in polar micro-environments while in absence of hydrogen bound-147
ing the relative dielectric constant εr is the main governing parameter [44].148
Comparing two solvents with approximately the same εr, e.g. acetone and149
1-propanol, the dominating influence of proticity on gxx and Azz becomes150
evident (see table 1).151
Previously, the unmodified spin label PCA when loaded to CMS nanoparti-152
cles (PCA@CMS) was investigated [14]. There, a highly polar environment153
was found for PCA and it was concluded that PCA is located at the surface154
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of the CMS. The magnetic parameters of DxPCA loaded to nanoparticples155
(DxPCA@CMS) determined here (g-matrix principal values (2.00865, 2.0061,156
2.0021) and A-matrix principal values (14, 14, 98) MHz) clearly deviate from157
those found for PCA@CMS in the preceding study [14]. DxPCA@CMS val-158
ues represent a micro-environment of intermediate polarity as visualized in159
fig. 2. This corresponds to the interface region between the inner hydropho-160
bic core and the hydrophilic outer shell of the CMS. Dx is a hydrophobic161
drug (logP=1.83) and even though unbound PCA shows a hydrophilic be-162
havior (logP=−1.7) DxPCA (logP=1.89) shows a very similar hydrophobic163
behavior as unmodified Dx. It is thus interesting to find DxPCA in a re-164
gion of intermediate polarity within the CMS. The g and hfc parameters165
determined above strongly depend on the relative unpaired spin density at166
the nitrogen and the oxygen atoms of the NO function, and, thereby, report167
on the micro-environment of the spin label via the electronic structure. A168
magnetic parameter probing complementary aspects of micro-environment169
properties is the the spin-lattice relaxation time T1 [46, 47]. It is sensitive to170
molecular vibrations and, thereby, provides information on mechanical prop-171
erties of the micro-environment. Thus, inversion recovery measurements were172
performed in addition to the EPR experiments discussed above. The corre-173
sponding time traces are shown in fig. 3. The time traces were fitted by a174
bi-exponential function (see Tab. 2). The obtained fit parameters are given175
in Tab.2. The the larger time constant τ1 occurring with about twice the176
amplitude than the shorter time constant τ2 was considered as the relevant177
T1 time [47]. Comparison of the T1 (i.e. τ1 in Tab. 2) for PCA and DxPCA in178
water shows very similar T1 times for both species, which are clearly distinct179
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Table 1: Magnetic Parameters of DxPCA in different solvents (Error margins in
the last digit given in parenthesis), together with polarities and relative dielectric
permetivities of the used solvents; (p) protic, (a) is aprotic.
Solvent g-matrix A-matrix (MHz) ENT [42] εr [45]
gxx, gyy , gzz Axx, Ayy , Azz
CMS 2.00865(2), 2.0061(2), 2.0021(4) 14, 14, 98(1)
Water (p) 2.00810(2), 2.0060(2), 2.0021(4) 15, 15, 104(1) 1 80.4
Ethanol(p) 2.00844(4), 2.0060(2), 2.0021(5) 15, 15, 101(1) 0.654 24.3
1-propanol(p) 2.00853(3), 2.0060(5), 2.0021(1) 13, 13, 101(1) 0.617 20.1
1-decanol(p) 2.00860(2), 2.0061(3), 2.0021(3) 13, 12, 99(1) 0.519 8.1
DMSO(a) 2.00864(4), 2.0060(3), 2.0021(1) 15, 15, 100(1) 0.444 46.68
Acetone(a) 2.00870(3), 2.0061(2), 2.0022(1) 15 15, 96(1) 0.355 20.7
Methyl formate(a) 2.00865(5), 2.0060(2), 2.0021(1) 15, 15, 98(1) 0.346 8.5
Toluene(a) 2.00900(5), 2.0061(3), 2.0021(3) 15, 15, 95(1) 0.099 2.4
PCA@CMS [14] 2.00890, 2.00600 , 2.0012 30, 35, 72
PCA@Water (p) 2.00805(3), 2.00596(2), 2.00212(2) 15, 15, 105(1) 1 80.4
from the T1 time for DxPCA@CMS. This corroborates the finding above that180
DxPCA experiences an environment different from the water phase and is181
within the CMS.182
3.2. Spin probe mobility in CMS nanoparticles183
The spectral shape arising for room temperature measurements, as for184
the low temperature, again depends on the g- and A-matrix as well as the185
experimental microwave frequency, but in addition is strongly determined by186
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Table 2: Spin lattice relaxation time T1 obtained by bi-exponential fitting of
inversion recovery time traces to the function f(t) = 1−2(A1e(−τ/τ1)+A2e(−τ/τ2)).
Material A1 τ1 (us) A2 τ2 (us)
DxPCA@CMS 0.67 240 0.33 31
DxPCA 0.70 379 0.30 26
PCA 0.68 398 0.32 32
the mobility of the spin probe [48, 49]. Variations in the mobility due to the187
different spin probe micro-environments manifest clearly in the line-width,188
line shape and hyperfine splitting in X-band (9 GHz) spectra recorded at189
ambient temperatures. The spectrum of small free nitroxide spin probes in190
isotropic solution with low viscosity, corresponding to rotational correlation191
times (τcorr) of 100 ps or faster at X-band frequencies, consists of three sharp192
lines. For slower tumbling due to a more viscous or anisotropic environment,193
the three lines become broader. The characteristic rotational correlation time194
τcorr for this regime is in the range of 300–1000 ps at X-band frequencies. The195
spectra become significantly broadened for further immobilized spin probes,196
where particularly the low field peak (1st line) and high field peak (3rd line)197
are sensitive for broadening. Quantitative values for τcorr can be extracted198
from the spectra by simulation [48]. The optimum EPR frequency band for199
monitoring spin label dynamics depends on the relevant rotational correlation200
times. Here, experiments at X-band frequencies were found to be adequate.201
Both the spectra of PCA and DxPCA show three sharp lines in aqueous so-202
lution with approximately equal height (Figure: 4, top and middle spectra)203
in agreement with the small effective radius and the low viscosity solvent.204
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The slightly larger effective radius of DxPCA compared to PCA results in205
a slower rotation and in consequence yields the slightly broadened and less206
intense high field peak for DxPCA. Spectral simulation reveals rotational207
correlation times of about 10 ps and 80 ps for PCA and DxPCA, respec-208
tively. These numbers are in good agreement with the rotational correla-209




). In the DxPCA spectrum a further spectral contribution can211
be seen as a broad unstructured line between the first and the second sharp212
line. This contribution is due to the low solubility of Dx in water, causing213
a partial aggregation of DxPCA. These aggregates likely contain a high Dx-214
PCA concentration with distances between DxPCA molecules giving rise to215
substantial spin-spin coupling, which in turn results in a strongly broadened216
spectrum devoid of the otherwise characteristic hyperfine sturcture.217
The spectrum of DxPCA@CMS (Figure: 4, bottom spectrum) clearly con-218
sists of two components. The first component consists of the characteristic219
three narrow and sharp lines. The second component is in this case a broad220
signal well visible to the left of the first sharp line. Again, the sharp lines221
represent a highly mobile fraction of DxPCA, indicative for the presence222
of free DxPCA in solution not loaded to CMS. The broad spectral contri-223
bution (see fig. 5, bottom spectrum) was extracted by subtracting the free224
DxPCA component from the DxPCA@CMS spectrum. The resulting spec-225
tral component is representative for the intermediate mobility range between226
the fast tumbling and the solid state regime and can be qualitatively simu-227
lated under the assumption of a rotational correlation time τcorr ≈ 7 ns. This228
number clearly shows a severely slowed rotational motion of DxPCA loaded229
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to CMS compared to DxPCA in aqueous solution. An interpretation of the230
rotational correlation time in terms of the DxPCA mobility within CMS is231
possible, when first considering the rotational correlation time of the CMS232
nanoparticles. Their average diameter was determined by dynamic light scat-233




), we calculate a rotational correlation time (τCMS ' 1µs). Such235
a very slow rotational correlation time yields in simulations spectra virtu-236
ally indistinguishable from the solid state limit. Thus, we can conclude that237
the rotational motion of the whole CMS nanoparticles has no influence on238
the observed spectral shape and the τcorr ≈ 7 ns derived for DxPCA@CMS239
exclusively reports the residual mobility of DxPCA within the CMS. The240
deconvolution of the DxPCA@CMS spectrum allows a further conclusion241
on the relative amounts of free DxPCA in solution and DxPCA loaded to242
CMS. Even though the peak amplitudes of the narrow three lines for the243
free DxPCA component are substantially larger than that of the broad Dx-244
PCA@CMS component, the ratio between free and loaded DxPCA amounts245
to 1:20. This shows that the equilibrium between DxPCA@CMS and free246
DxPCA in the aqueous solution is strongly shifted to DxPCA loaded to the247
CMS.248
3.3. Skin penetration of DxPCA loaded to CMS249
The penetration of DxPCA@CMS into porcine ear skin was investigated250
again by room temperature X-band EPR in comparison to DxPCA dissolved251
in a water/5% EtOH solution 4 and 24 hours after topical application of252
both sample types. In both cases an increase of the EPR signal can be seen253
between the measurements performed after 4 h incubation and that after254
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24 h (fig. 6). For DxPCA dissolved in a water/5% EtOH solution one sin-255
gle broadened peak is hardly visible in the spectrum recorded after 4 h and256
becomes better visible after 24 h (fig. 6 left) at the spectral position corre-257
sponding to the center line of the typical three line nitroxide spectrum. In258
contrast to this result, the spectra for DxPCA@CMS show for both times259
the characteristic three line nitroxide EPR spectrum (fig. 6 right). The in-260
tensity of this spectral contribution remains largely unchanged. In addition261
to the narrow line spectrum, a second broadened contribution is visible at262
both times, mainly as intensity between the first and second peaks of the263
narrow line spectrum. This spectral contribution increases in intensity rela-264
tive to the narrow component in the spectrum taken after 24 h. We assign265
the two spectral contributions visible for DxPCA@CMS again as before. The266
three line spectrum represents free DxPCA while the broadened component267
is due to DxPCA still incorporated into CMS. The increased intensity of the268
broad component after 24 h compared to the 4 h spectrum recorded for Dx-269
PCA@CMS incubation on skin reports thus an enhanced CMS nanoparticle270
penetration into the porcine ear skin with time.271
Whether DxPCA@CMS and the free DxPCA penetrate into the porcine272
ear skin or only form a surface layer can be tested by the tape stripping273
method (see e.g. [36]). Figure 7 shows X-band EPR spectra of DxPCA ap-274
plied onto porcine ear skin after 24 h incubation time and removal of the275
supernatant followed by removal of 1, 2, and 3 tapes. After removal of the276
first layers of the SC a strong difference in the penetration efficiency for two277
different DxPCA application schemes becomes apparent: DxPCA dissolved278
in the water/5% EtOH solution solution shows for the whole porcine ear279
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skin one broadend EPR signal, which strongly diminishes after removing the280
first adhesive tape and has virtually disappeared after removing the second.281
For DxPCA@CMS the EPR signal decreases gradually after stripping of one282
to three adhesive tapes. Within the limited signal-to-noise ratio, the ratio283
between the free DxPCA and the DxPCA@CMS components seems to be284
unchanged (Fig. 7). These results are in agreement with the investigation285
of Küchler et al. showing the skin penetration of CMS using a lipophilic286
fluorescent dye [18] .287
A remaining question is whether the CMS particles transport only DxPCA288
loaded into them or whether they act as a general penetration enhancer pro-289
moting co-transport of the DxPCA outside them. To address this question290
we prepared a mixture of 90 µM DxPCA aqueous/5% EtOH solution and291
empty CMS particles. This mixture was applied in the same way as the292
DxPCA@CMS sample onto porcine ear skin, incubated for 24 hours and293
subjected to tape stripping (fig. 7C). Again only a single line EPR signal is294
visible for the porcine ear skin before and after tape stripping, and signal in-295
tensity is - if at all - only weakly increased compared to the aqueous DxPCA296
solution without CMS (fig. 7A). Thus, a co-transport of DxPCA by CMS297
can be only of minor importance and the deeper penetration of DxPCA into298
the skin when applied after loading into CMS is in the vast majority due to299
direct transport as cargo within the CMS.300
4. Conclusion301
The presented investigations have shown that EPR is able to provide302
evidence for the loading of Dx into CMS nanoparticles and for the Dx loca-303
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tion within the nanoparticles. Thereby, we have made use of complementary304
magnetic parameters of the spin label PCA covalently attached to the drug305
Dexamethasone. The g- and A-matrices of DxPCA report on the polar-306
ity/proticity of its micro-environment while the spin-lattice relaxation time307
T1 probes vibrational properties of the DxPCA micro-environment. These308
magnetic parameters were measured by pulsed high-field EPR and clearly309
show a location of DxPCA within the CMS nanoparticles in a region of310
intermediated polarity, likely the interface between the hyrdophobic and hy-311
drophilic shells of the CMS. Furthermore, we determined dynamical informa-312
tion on the drug in aqueous solution and loaded into the CMS nanocarriers313
using continuous wave EPR at ambient temperature. The differences found314
in the dynamics between freely dissolved DxPCA and DxPCA loaded into315
CMS was used to analyse the drug/carrier penetration behaviour into skin.316
Thereby, we could show that the penetration of the drug into the porcine317
ear skin is facilitated only for the drug loaded into the CMS and that a co-318
transport of the drug through a lowered skin barrier by CMS is of only minor319
importance if at all relevant.320
Chemical compounds studied in this article321
• Dexamethasone (PubChem CID: 5743)322
• 3-(Carboxy)-2,2,5,5-tetramethyl-1-pyrrolidinyloxy (PubChem CID: 519874)323
• Ethanol (PubChem CID: 702)324
• 1-propanol (PubChem CID: 1031)325
• 1-decanol (PubChem CID: 8174)326
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• DMSO (PubChem CID: 679)327
• Acetone (PubChem CID: 180)328
• Methyl formate (PubChem CID: 7865)329
• Toluene (PubChem CID: 1140)330
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Figure 1: W-Band EPR spectra of DxPCA in different environments at 80 K;
solid line: experiment, dashed line: simulation, All spectra were normalised to a
















































































Figure 2: Dependence of gxx and Azz of DxPCA on different solvents and linear
fits (both lines, respectively). The areas filled in black and white mark the polarity
range compatible with the DxPCA@CMS gxx and Azz parametrers, repectively
.
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Figure 3: Inversion recovery spin-lattice relaxation time (T1) measurement for
DxPCA@CMS (solid line), DxPCA@Water(dash line) and PCA@Water(dot dash)
at W-band, 80 K; solid line: experiment, dashed line: bi-exponential fit)
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Figure 4: EPR spectra DxPCA@CMS (bottom spectrum), DxPCA in water (mid-
dle spectrum) and PCA in water (top spectrum) measured at X-band and room
temperature. Experimental parameters are for DxPCA@CMS: microwave power:
50 mw, field modulation amplitude: 3 G; for DxPCA in water: microwave power:
20mW, field modulation amplitude: 5 G, PCA in water: microwave power: 25 mW,
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Figure 5: Deconvolution of the DxPCA@CMS spectrum into the free DxPCA
spectral contribution and a partly immobilised DxPCA spectral contribution. The
experimental DxPCA@CMS spectrum (top spectra) is as in fig. 4; the free DxPCA
in water spectrum (top dash line) is a simulation of corresponding spectrum in fig.
4. The resulting spectrum after subtraction is given by the bottom line.29
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Figure 6: EPR spectra of DxPCA after topical application on porcine ear skin:
(left) DxPCA dissolved in a water/5% EtOH solution (90 µM) and (right) Dx-
PCA@CMS, both after an incubation time of 4 h (A) and 24 h (B). Each spectrum
is an average of three measurements at X-band and room temperature.
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Figure 7: EPR spectra of DxPCA after topical application on porcine ear skin
(A): DxPCA dissolved in a water/5% EtOH solution (90 µM), (B) DxPCA@CMS,
and (C) a mixture of DxPCA dissolved in a water/5% EtOH solution (90 µM) and
empty CMS particles, all after an incubation time of 24 h and after the indicated
numbers of tape stripping. Each spectrum is an average of three measurements at
X-band and room temperature.
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